Stocks
GlaxoSmithKline (GSK) P/E US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 16.1 | 0.00 | 0.00 | 26.8 | 17.4 | 17.5 | ||
| Changes by years, y/y, % | +26% | -100% | -35% | +6.4% | |||||
GlaxoSmithKline. P/E
GlaxoSmithKline. P/E, changes, %
GlaxoSmithKline (GSK) P/E US GAAP (quarter values) |
||||||||
| FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| P/E | ? | 17.2 | 8.62 | 19.0 | 21.8 | 21.8 | 17.5 | |
| Changes by years, y/y, % | -36% | -68% | -24% | -4% | -4% | |||
| Changes by quarters, q/q, % | +9% | -50% | +121% | +15% | 0% | |||
